Costco Wholesale, McKesson, Starbucks
Corrects named item code to RCH/US from RCH/EUROPE; a previous version was corrected to fix headline tag to US RESEARCH ROUNDUP from EUROPE RESEARCH ROUNDUP and to change media packaging code to RESEARCH-US/
Sept 24 (Reuters) -Securities analysts revised their ratings and price targets on several European companies, including Costco Wholesale, McKesson and Starbucks on Tuesday.
HIGHLIGHTS
* Costco Wholesale Corp COST.O: Raymond James raises target price to $980 from $880 |
* McKesson Corp MCK.N: Baird cuts target price to $531 from $603 |
* Starbucks SBUX.O: Jefferies cuts to underperform from hold |
Following is a summary of research actions on European companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Biohaven Ltd BHVN.N: RBC raises target price to $68 from $59 |
* Black Diamond Therapeutics BDTX.O: Piper Sandler raises target price to $15 from $12 |
* BP BP.N: Jefferies cuts target price to $40.1 from $43.8 |
* Braze Inc BRZE.O: Canaccord Genuity cuts target price to $45 from $53 |
* Bread Financial Holdings Inc BFH.N: Jefferies cuts target price to $50 from $55 |
* Celsius Holdings Inc CELH.O: Piper Sandler cuts target price to $47 from $50 |
* Church & Dwight Co Inc CHD.N: Piper Sandler initiates with overweight rating; PT $120 |
* Colgate-Palmolive Co CL.N: Piper Sandler initiates with overweight rating; target $121 |
* Costco Wholesale Corp COST.O: Raymond James raises target price to $980 from $880 |
* Crowdstrike CRWD.O: Jefferies raises target price to $345 from $315 |
* Dayforce Inc DAY.N: Keybanc initiates coverage with overweight rating; target price $70 |
* Equinix Inc EQIX.O: CFRA cuts to hold from buy |
* Ideaya Biosciences Inc IDYA.O: Wedbush cuts target price to $52 from $54 |
* Kenvue Inc KVUE.N: Jefferies initiates coverage with buy rating; target price $27 |
* Kenvue Inc KVUE.N: RBC cuts to sector perform from outperform |
* Lamb Weston Holdings Inc LW.N: TD Cowen raises target price to $65 from $61 |
* McKesson Corp MCK.N: Baird cuts target price to $531 from $603 |
* McKesson Corp MCK.N: Baird cuts to neutral |
* Okta Inc OKTA.O: Jefferies cuts target price to $85 from $100 |
* P&G PG.N: Piper Sandler initiates coverage with neutral rating; target price $174 |
* Prestige Consumer Healthcare PBH.N: Jefferies assumes with hold vs buy rating; PT $76 vs $70 |
* Procore Technologies PCOR.N: Baird initiates coverage with outperform rating; PT $73 |
* Replimune Group Inc REPL.O: JP Morgan raises target price to $17 from $14 |
* Shake Shack Inc SHAK.N: JP Morgan cuts target price to $102 from $105 |
* Sharkninja Inc SN.N: Canaccord Genuity raises target price to $126 from $105 |
* Starbucks SBUX.O: Jefferies cuts to underperform from hold |
* Starbucks SBUX.O: Jefferies cuts target price to $76 from $80 |
* Tradeweb Markets Inc TW.O: Jefferies raises target price to $118 from $109 |
* Vistra Corp VST.N: Jefferies raises target price to $137 from $99 |
* Zevra Therapeutics Inc ZVRA.O: Canaccord Genuity raises target price to $25 from $22 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
